Find More Contacts for NightHawk Biosciences
Protected Content
VP
VP Management
1 email found
View contacts for NightHawk Biosciences to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email info@heatbio.com
  • Phone Number 9192407540

Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) adjuvant technology for use in a number of oncology and infectious disease indications. Heat’s ImPACT therapy is a first-in-class fully human adjuvant system that functions as both an immune stimulator and an

antigen-delivery system. ImPACT is rapidly applied to a selected off-the-shelf cancer cell line to effectively transform living tumor into powerful machines that “pump out” their full antigenic fingerprint to robustly stimulate the immune system against the targeted disease. ImPACT is applicable to a wide range of cancers as well as infectious diseases including HIV, HCV and malaria. Heat is currently in Phase II clinical trials with its first drug to treat Non Small Cell Lung Cancer (NSCLC) and plans to initiate clinical trials against additional cancers in 2012.

Lists Featuring This Company

United States Companies With Fewer Than 100 Employees (Top 10K)
9,878 Number of Organizations • $471.7B Total Funding Amount • 81,096 Number of Investors
Southern US Companies With Less Than $50M in Revenue (Top 10K)
9,866 Number of Organizations • $271.2B Total Funding Amount • 28,951 Number of Investors
Research Triangle Medical Companies
715 Number of Organizations • $5.3B Total Funding Amount • 398 Number of Investors
Southern US Companies (Top 10K)
9,404 Number of Organizations • $861.8B Total Funding Amount • 33,809 Number of Investors

Frequently Asked Questions

Where is NightHawk Biosciences's headquarters? NightHawk Biosciences is located in Chapel Hill, North Carolina, United States.Who invested in NightHawk Biosciences? NightHawk Biosciences is funded by Square 1 Bank.How much funding has NightHawk Biosciences raised to date? NightHawk Biosciences has raised .When was the last funding round for NightHawk Biosciences? NightHawk Biosciences closed its last funding round on Dec 12, 2023 from a Post-IPO Debt round.Who are NightHawk Biosciences's competitors? Alternatives and possible competitors to NightHawk Biosciences may include Aura BiosciencesAsklepios BioPharmaceutical, and CEL-SCI.